Chugai Pharmaceutical Co., Ltd. (CHGCF)
OTCMKTS
· Delayed Price · Currency is USD
40.21
-2.20 (-5.20%)
At close: Jan 22, 2025
Chugai Pharmaceutical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 69,267 | 62,351 | 42,013 | 53,339 | 87,648 | 50,778 | Upgrade
|
| Market Cap Growth | 56.31% | 48.41% | -21.23% | -39.14% | 72.61% | 59.58% | Upgrade
|
| Enterprise Value | 63,848 | 57,961 | 37,878 | 49,894 | 84,559 | 48,145 | Upgrade
|
| Last Close Price | 39.76 | 36.73 | 25.41 | 32.08 | 45.92 | 63.59 | Upgrade
|
| PE Ratio | 25.64 | 27.00 | 14.80 | 20.27 | 42.13 | 35.02 | Upgrade
|
| PS Ratio | 9.99 | 7.91 | 4.40 | 6.14 | 11.49 | 8.04 | Upgrade
|
| PB Ratio | 6.33 | 5.41 | 3.89 | 5.17 | 9.23 | 6.46 | Upgrade
|
| P/TBV Ratio | 6.41 | 5.47 | 3.96 | 5.27 | 9.46 | 6.65 | Upgrade
|
| P/FCF Ratio | 32.50 | 26.00 | 30.53 | 28.74 | 61.12 | 35.92 | Upgrade
|
| P/OCF Ratio | 27.20 | 21.44 | 22.70 | 21.96 | 44.12 | 26.71 | Upgrade
|
| EV/Sales Ratio | 8.72 | 7.35 | 3.96 | 5.75 | 11.09 | 7.63 | Upgrade
|
| EV/EBITDA Ratio | 17.41 | 17.35 | 8.84 | 12.69 | 26.32 | 22.08 | Upgrade
|
| EV/EBIT Ratio | 18.44 | 18.60 | 9.37 | 13.62 | 28.97 | 24.84 | Upgrade
|
| EV/FCF Ratio | 26.06 | 24.17 | 27.52 | 26.89 | 58.97 | 34.06 | Upgrade
|
| Debt / Equity Ratio | - | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.03 | 0.02 | 0.04 | 0.03 | 0.05 | Upgrade
|
| Debt / FCF Ratio | - | 0.04 | 0.08 | 0.08 | 0.08 | 0.08 | Upgrade
|
| Asset Turnover | 0.59 | 0.58 | 0.74 | 0.72 | 0.69 | 0.69 | Upgrade
|
| Inventory Turnover | 1.22 | 1.46 | 1.90 | 1.72 | 1.55 | 1.62 | Upgrade
|
| Quick Ratio | 4.67 | 3.68 | 2.40 | 2.53 | 2.68 | 2.87 | Upgrade
|
| Current Ratio | 5.89 | 4.74 | 3.15 | 3.25 | 3.54 | 3.90 | Upgrade
|
| Return on Equity (ROE) | 23.20% | 21.34% | 28.67% | 27.95% | 23.42% | 19.57% | Upgrade
|
| Return on Assets (ROA) | 17.37% | 14.44% | 19.56% | 19.01% | 16.41% | 13.31% | Upgrade
|
| Return on Capital (ROIC) | 20.24% | 17.84% | 25.23% | 24.02% | 20.27% | 16.21% | Upgrade
|
| Earnings Yield | 3.90% | 3.70% | 6.76% | 4.93% | 2.37% | 2.86% | Upgrade
|
| FCF Yield | 3.54% | 3.85% | 3.28% | 3.48% | 1.64% | 2.78% | Upgrade
|
| Dividend Yield | 0.63% | 1.55% | 2.33% | 2.06% | 1.16% | 0.46% | Upgrade
|
| Payout Ratio | 34.45% | 40.43% | 36.91% | 32.56% | 42.58% | 35.78% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.01% | -0.01% | -0.01% | -0.03% | -0.05% | Upgrade
|
| Total Shareholder Return | 0.62% | 1.54% | 2.32% | 2.05% | 1.13% | 0.42% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.